REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $119,000 | -99.5% | 611 | -99.5% | 0.05% | -97.5% |
| Q4 2020 | $24,803,000 | +39.0% | 129,430 | +7.1% | 1.83% | +18.4% |
| Q3 2020 | $17,838,000 | +177.7% | 120,906 | -22.0% | 1.55% | +164.7% |
| Q2 2017 | $6,423,000 | +858.7% | 155,000 | +613.3% | 0.58% | +784.8% |
| Q4 2016 | $670,000 | -1.6% | 21,730 | -3.6% | 0.07% | 0.0% |
| Q3 2016 | $681,000 | +18.0% | 22,550 | +6.9% | 0.07% | +11.9% |
| Q2 2016 | $577,000 | +1.9% | 21,100 | 0.0% | 0.06% | +3.5% |
| Q1 2016 | $566,000 | -5.2% | 21,100 | 0.0% | 0.06% | +1.8% |
| Q4 2015 | $597,000 | +114.0% | 21,100 | +50.7% | 0.06% | +133.3% |
| Q3 2014 | $279,000 | -93.9% | 14,000 | -96.1% | 0.02% | -93.3% |
| Q1 2014 | $4,559,000 | +637.7% | 354,500 | +372.7% | 0.36% | +643.8% |
| Q2 2013 | $618,000 | – | 75,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |